{"id":"W2014046273","doi":"10.1097/jcp.0000000000000192","title":"A Randomized, Double-Blind, Placebo-Controlled Pilot Study of Naltrexone to Counteract Antipsychotic-Associated Weight Gain","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Psychopharmacology","topic":"Diet and metabolism studies","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Institute of Mental Health; Genentech; National Institute of Diabetes and Digestive and Kidney Diseases; Gilead Sciences; Pfizer; National Institutes of Health; H. Lundbeck A/S; Yale University; Eli Lilly and Company","keywords":"Weight gain; Schizoaffective disorder; Medicine; Naltrexone; Antipsychotic; Overweight; Placebo; Schizophrenia (object-oriented programming); Weight loss; Population; Overeating; Randomized controlled trial; Internal medicine; Psychiatry; Psychosis; Body mass index; Obesity; Opioid; Body weight","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01386844,0.000368633,0.006007329,0.0005325892,0.00007742353,0.00001761684,0.0003693069,0.0001666603,0.0004038379],"category_scores_gemma":[0.004537185,0.0002424088,0.001012537,0.0004356021,0.0002392336,0.0001077201,0.00006044183,0.001110789,0.00005550402],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003525167,"about_ca_system_score_gemma":0.0001841931,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001546622,"about_ca_topic_score_gemma":0.00002469358,"domain_scores_codex":[0.9911944,0.002203344,0.004936295,0.0003923104,0.0008055533,0.0004681137],"domain_scores_gemma":[0.9883833,0.00627573,0.003105907,0.0003110359,0.001316147,0.0006078673],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9387667,0.01811842,0.007288328,0.0000326911,0.006506979,0.00007451135,0.0004627623,0.00002950876,0.001395499,0.00003735714,0.02581519,0.001472019],"study_design_scores_gemma":[0.9575643,0.01983726,0.01126364,0.0001411192,0.004699153,0.00002675512,0.0001775671,0.000122975,0.00003866723,0.0001326382,0.00580344,0.0001924925],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9769069,0.000546243,0.0001951393,0.004163861,0.009746516,0.003215121,0.000002871735,0.0000222848,0.005201087],"genre_scores_gemma":[0.9911928,0.001058717,0.0002828359,0.004025477,0.002437779,0.00008112237,0.000001391365,0.00004092351,0.0008790041],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02001175,"threshold_uncertainty_score":0.9885142,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09343165729162792,"score_gpt":0.4608440513090553,"score_spread":0.3674123940174273,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}